Publication2024
Advanced biomaterials for regenerative medicine and their possible therapeutic significance in treating COVID-19: a critical overview
The record
- Type
- Publication
- Date
- 1 December 2024
- Level
- International — held abroad
- Journal
- International Journal of Surgery London England
- Volume
- 110
- Issue
- 12
- Pages
- 7508-7527
- Published
- 1 December 2024
- DOI
- 10.1097/js9.0000000000002110
- Scopus ID
- 85215647461
- ISSN
- 17439159
- Authors
- 22
- Open access
- Yes
- Citations
- 12
- International co-authorship
- Yes
- Co-author countries
- EG, IN, SA
Classification
Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.
UN Sustainable Development Goals
3.3 End the epidemics of AIDS, tuberculosis, malaria, neglected tropical diseases, hepatitis and water-borne diseases
Reviews advances in biomaterial-based stem cell therapies and scaffolding technology for tissue repair and COVID-19 immunological dysregulation management with clinical validation pathways
- High confidence
- The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
- Judged
- Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
9.5 Enhance scientific research, upgrade technological capabilities, and increase researchers and R&D spending
Synthesizes advances in scaffold construction, bioengineered stem cells and biomaterial design strategies for translational regenerative medicine applications
- Moderate confidence
- The alignment is plausible and defensible but rests on an assumption a reasonable reviewer could decline. Published, and surfaced in the review queue for a human to confirm or override.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
17.6 Enhance North-South, South-South and triangular cooperation on science, technology and innovation, and knowledge sharing
Structural signal: co-authorship outside India.
- Rule-derived
- Emitted by a deterministic rule from structural signals rather than judged from the record’s text. The rule carries a version, so rule-derived and judged labels stay separable.
- Produced by
- sdg17-structural-v1, under kortex-publication-v1
Viksit Bharat @2047
vb-1.2 Health and well-being
Regenerative medicine research advances therapeutic approaches for infectious disease management and tissue restoration for improved health outcomes
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Each label above carries the instrument and the version that produced it. How each classification is reached.
Evidence
Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.
No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.
Provenance
Which source system this record came from, how many source rows were resolved into it, and when each was last read.
- Source rows resolved into this record
- 1
Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.
Citing this record
This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.
KIIT Deemed to be University. “Advanced biomaterials for regenerative medicine and their possible therapeutic significance in treating COVID-19: a critical overview”. Kortex.